Review Article
Intravenous Fosfomycin: An Assessment of Its Potential for Use in the Treatment of Systemic Infections in Canada
Table 1
The 20 most common bacterial pathogens isolated from patient samples in Canadian hospitals, CANWARD surveillance study, 2007–2016.
| Rank | Organism | Number of isolates | % of total isolates |
| 1 | Escherichia coli | 8,387 | 19.5 | 2 | Staphylococcus aureus, MSSA | 7,146 | 16.6 | 3 | Pseudomonas aeruginosa | 3,864 | 9.0 | 4 | Streptococcus pneumoniae | 2,626 | 6.1 | 5 | Klebsiella pneumoniae | 2,624 | 6.1 | 6 | Staphylococcus aureus, MRSA | 1,963 | 4.6 | 7 | Haemophilus influenzae | 1,764 | 4.1 | 8 | Coagulase-negative staphylococci/Staphylococcus epidermidis | 1,616 | 3.8 | 9 | Enterococcus faecalis | 1,255 | 2.9 | 10 | Enterobacter cloacae | 1,060 | 2.5 | 11 | Streptococcus agalactiae | 689 | 1.6 | 12 | Stenotrophomonas maltophilia | 669 | 1.6 | 13 | Klebsiella oxytoca | 668 | 1.6 | 14 | Proteus mirabilis | 647 | 1.5 | 15 | Serratia marcescens | 647 | 1.5 | 16 | Streptococcus pyogenes | 642 | 1.5 | 17 | Enterococcus, nonspeciated | 582 | 1.4 | 18 | Enterococcus faecium | 481 | 1.1 | 19 | Candida albicans | 478 | 1.1 | 20 | Moraxella catarrhalis | 468 | 1.1 | | Others | 4,729 | 11.0 | Total | | 42,938 | |
|
|
|